Post of the Week: Anticholingergic drugs
Posted 21 November 2009 - 05:51 PM
Anticholinergic agents were the first widely accepted therapy for the symptomatic treatment of Parkinson’s disease (Katzenschlager et al 2005). Prior to 1969, doctors only had anticholinergic drugs to offer their patients! With increased knowledge of the adverse effects associated with their use and the introduction of levodopa and newer agents that provide better control of motor symptoms, the popularity of anticholinergics for use in Parkinson’s disease has taken a big hit. Although their precise mechanism of action remains unknown, the observed exacerbation of parkinsonian symptoms following their discontinuation suggests a clinical benefit.
A systematic review of clinical studies of anticholinergics in the symptomatic management of Parkinson’s disease concluded that anticholinergics are more effective than placebo in improving motor function (particularly tremor) with short-term use, but evidence of long-term efficacy is still lacking (Katzenschlager et al 2006).
While anticholinergics appear to be clinically useful in the treatment of tremor, their efficacy is only moderate and may not cover other (often more important) motor symptoms such as rigidity and bradykinesia. Their use is associated with safety concerns that limit their clinical utility. Anticholinergic side effects include blurred vision, urinary retention, constipation, and dry mouth. Additionally, they may significantly interfere with thinking, memory and concentration, especially in the elderly patient with Parkinson’s disease. Examples of anticholinergic drugs are trihexyphenidyl and benztropine. Thus, while anticholinergic agents are one of the cheapest drugs used in Parkinson’s disease, they are not the treatment of choice, except perhaps for young patients with significant but treatment-resistant tremor.
There have been studies suggesting that anticholinergics may adversely affect cognitive function and result in changes in the brain that look like Alzheimer’s disease. These findings are unconfirmed and only reported in a small number of post-mortem brains.
- Gautam likes this
Posted 05 February 2010 - 06:32 PM
Son has been on it since about 1993 when diagnosed with MS and then correctly diagnosed with PD. He is now 51.
Posted 07 February 2010 - 08:53 AM
Michael S. Okun, M.D.
Author of Amazon Kindle, Paperback and Audio of 10 Breakthrough Therapies for Parkinson's Disease
Author of the Amazon Bestseller Parkinson's Treatment: 10 Secrets to a Happier Life
National Medical Director | NPF
UF Center for Movement Disorders & Neurorestoration
Read More about Dr. Okun at: http://movementdisor...hael-s-okun-md/
or Visit Parkinson's Disease treatment and research blogs at:
NPF's What's Hot in Parkinson's disease
or his parkinsonsecrets.com blog for treatment tips
Posted 26 February 2010 - 05:27 PM
What withdrawal schedule would you suggest ti tapering off and finally being off completely.
Posted 27 February 2010 - 11:00 AM
Talk to your doctor about this. I would suggest something like 2.5 in the morning and 5 at night for 1 week; then 2.5 twice per day, then 2.5 once per day, then no more on a weekly basis.
0 user(s) are reading this topic
0 members, 0 guests, 0 anonymous users